Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Vaccine progress injects optimism into global stocks

Published 11/09/2020, 07:25 PM
Updated 11/09/2020, 09:15 PM
© Reuters. FILE PHOTO: A man works at the Tokyo Stock Exchange after market opens in Tokyo

By Lawrence Delevingne

BOSTON (Reuters) - Global stocks and oil jumped and Treasuries sold off on Monday as progress in the development of a coronavirus vaccine lifted investor confidence in a world economic recovery.

"Preliminary trials have caused markets to come alive, not that they needed much encouragement," Chris Weston, Pepperstone's Melbourne-based head of research, wrote in a note Monday.

Pfizer Inc (NYSE:PFE) said its COVID-19 vaccine, developed with German partner BioNTech SE (NASDAQ:BNTX), was more than 90% effective in preventing infection, marking the first successful results from a large-scale clinical trial.

On Wall Street, the Dow Jones Industrial Average rose 2.95%, the S&P 500 gained 1.17% while the Nasdaq Composite dropped 1.53%. E-mini futures for the S&P 500 rose 0.47%.

Japan's Nikkei 225 rose 1.5% to a 29-year high in early trade and Australia's S&P/ASX 200 rose 1.4%. Hong Kong's Hang Seng index futures rose 1.85%. MSCI's broadest index of Asia-Pacific shares outside Japan closed 0.12% higher.

Pfizer's announcement jolted European shares to an eight-month high, building on expectations of more stable trade policies following the U.S. election.

While stocks have also rallied on the assumption that Democrat Joe Biden would be the next U.S. President, the top Republican in U.S. Congress on Monday did not acknowledge Biden as president-elect, raising concerns about a rough transition of power.

Senator Mitch McConnell said in a speech that President Donald Trump was well within his rights to look into charges of election "irregularities" but did not offer any evidence of fraud.

The dollar index rose 0.65%, but Joseph Capurso, a strategist with Commonwealth Bank of Australia (OTC:CMWAY) in Sydney, expects the move to be short-lived.

"As a counter cyclical currency, the USD falls against most currencies as the global economy improves, with the exception of the JPY," Capurso wrote. He noted modeling suggested the dollar was "significantly undervalued" against the yen.

The Australian dollar fell 0.07% versus the greenback at $0.728.

The Japanese yen strengthened 0.25% versus the greenback to 105.09 per dollar, while Sterling was last trading at $1.3171, up 0.06% on the day.

The vaccine news also sent long-dated U.S. Treasury yields sky-rocketing in their biggest one-day jump since March. The yield curve, an indication of risk appetite, hit its steepest level since March.

Benchmark 10-year notes last fell 31/32 in price to yield 0.9235%, from 0.82% late on Friday.

The CBOE Market Volatility index, a barometer of investor anxiety, hit its lowest closing level since late August.

Oil prices surged, posting their biggest daily percentage gain in more than five months as the vaccine news and an OPEC output deal fueled optimism about rebounding demand.

Gold prices slumped as investors pivoted away from the safe-haven metal in favor of riskier assets.

Spot gold added 0.4% to $1,868.68 an ounce.

© Reuters. FILE PHOTO: A man works at the Tokyo Stock Exchange after market opens in Tokyo

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.